BPD STAR Pilot Trial
Contact
Description
This study will test whether supplemental oxygen therapy, a common post-discharge treatment for BPD, improves outcomes. Enrolled infants, between the ages of 34-44 weeks Post Menstrual Age, with moderate or severe BPD, will be randomly assigned to higher or lower oxygen saturation target ranges. The study intervention will begin in the hospital and will continue at home until 6 months Corrected Age.
Eligibility and criteria
IRB Number:
17-014522
Clinical trial phase:
Pilot
Official title:
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.